The NHS exceeded all seven of its targets for cancer diagnosis and treatment during the last year, new data has revealed.
Bright Grey and Scottish Provident have sought to clarify breast cancer cover from critical illness (CI) providers following recent changes made to their definitions.
The National Institute for Health and Clinical Excellence (Nice) has rejected the use of Avastin for metastatic breast cancer on the NHS.
Julie Hopkins considers the case for adding partial benefit payment for DCIS treated with mastectomy and asks whether coverage could be extended to all DCIS diagnoses resulting in surgery